Published in:
Open Access
01-12-2018 | Commentary
How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors
Authors:
Gian Paolo Fadini, Angelo Avogaro
Published in:
Cardiovascular Diabetology
|
Issue 1/2018
Login to get access
Excerpt
In a review article on this
Journal, Milton Packer discusses the “potential confounding effect of stem-cell chemokines (SDF-1α)” on diabetic vascular complications during therapy with DPP-4 inhibitors [
1]. This misconception is also part of the underlying hypothesis in another author’s recent article [
2]. The purpose of this commentary is to show that such misinterpretation is not supported by data and derives from a partial and selective consideration of the literature. …